despite extensive research into new ways of imaging the breast x-ray mammography and breast ultrasound, supplemented where necessary by magnetic resonance imaging, remain the techniques used for the vast majority of breast imaging for screening and the assessment of symptomatic breast problems. Recent advances in these technologies mean that these three techniques are highly effective for both detecting disease and for confirming normality. X-ray based imaging of the breast has been around now for 100 years but it is only in the last 10 years or so that digital technology developments have allowed for major advances in the efficacy of this technique. digital breast tomosynthesis is currently the most promising technology as it has the potential to both improve detection of breast cancer and greatly reduce the numbers of false positive events. Technological advances in grey scale high frequency ultrasound imaging mean that it is now universally used in both symptomatic diagnosis and breast screening. Newer ultrasound techniques such as 3d imaging, doppler analyses and elastography add some additional value but so far none of these has achieved their hoped for additional potential. Magnetic resonance imaging is currently the most sensitive imaging technique for the detection and characterisation of breast disease, but its cost remains a barrier to its more widespread use. Nuclear medicine techniques have a role is special circumstances but are yet to show that they should be used in routine practice. There are a large number of potential alternative new imaging techniques for the breast, but, as yet, none of these have shown any significant benefits over the current techniques. dedicated breast computed tomography has perhaps the best promise but clinically effective breast imaging at present remains in the application and refinement of recent developments in digital mammography, ultrasound and magnetic resonance imaging.
X-ray Imaging
The use of X-ray mammography to produce a 2d image of the breast has been used for over 4 decades. although albert Solomon first reported the use of X-rays to image mastectomy specimens in 1913, 1 it was not until 1939 that Stafford Warren first reported its use in clinical practice. 2 Raul leborgne was the first to report mammography using breast compression in 1949 and through the 1950s and 1960s mammography became increasingly used for breast diagnosis. 3 The first commercial dedicated mammography machine was developed in 1966
by the compagnie Generale de Radiologie 4 in France and this machine is the model on which modern mammography is based. Since then there have been incremental improvements in mammographic technology, culminating in the introduction of digital mammography in the 1990s.
Mammography requires very high spatial resolution to detect the features of early breast cancer, particularly microcalcifications. The resolution limitation of digital imaging technology has meant that mammography has been the last X-ray-based radiology technique to transfer from film to digital acquisition, with the required image receptor technology only becoming available since the mid-1990s.
Mammography has been used successfully for population screening for breast cancer since the 1960s and mammographic screening is now available in most developed countries. The development of full field digital mammography (FFdM) using high-resolution receptors has provided the opportunity to significantly improve the performance and efficacy of mammography, particularly in screening for breast cancer and the assessment of the mammographically dense breast. 5 Breast density is important for two reasons. Firstly women with dense breasts have up to a fourfold increase in breast cancer risk and secondly having dense breasts reduces the chances of mammography detecting breast cancer by up to half. FFdM is equivalent to screen/film mammography in older women 5 as breast density is less of a problem, but, over the past decade, clinical trials have shown that here is a significant increase in cancer detection with FFdM in the dense breast. FFdM provides a wider range of grey scale and contrast, translating into significantly better performance in younger women and all women with denser breasts. 6 The digital image format also provides the ability to manipulate the image on high-resolution image display screens, allowing for the application of computer-aided detection of structures in other planes (see Figure 1) . Initial clinical studies have concluded that DBt leads to subjectively clearer delineation and more definitive identification of malignant lesions and their extent. 7 recent trials have shown that DBt greatly improves breast-screening sensitivity, reducing false positive results (Fpr) by up to 50 % while at the same time improving breast cancer detection. 8 DBt increases the conspicuity of malignant lesions, especially in women with increased parenchymal density, and, equally importantly, reduces the number of women recalled for further investigations that prove to be normal. 9 Digital mammography has also provided many logistic advantages that mean that mammography is now much more transferable and archiving much more cost-effective. 10 It is likely that DBt will become the standard technique for screening all women with denser breasts and is already being adopted as routine for further assessment of screen-detected abnormalities.
another new digital mammography method being introduced designed to improve the sensitivity of mammography in the dense breast is dual- 
Ultrasound
Breast ultrasound has long been adopted as the imaging technique of choice for younger women, as an adjunct to mammography for older women, for the further diagnostic evaluation of abnormalities identified on clinical palpation and is the technique of choice for needle breast biopsy. the advantages of ultrasound are that it is widely available, cheaper, more patient friendly and does not involve ionising radiation.
15-17
When combined with mammography, ultrasound provides increased sensitivity in detecting cancer compared with mammography alone. the increase in sensitivity for breast cancer has been reported to rise from 74-97 % when mammography is combined with ultrasound instead of clinical examination. ultrasound can also identify early small (less than 10 mm) node-negative breast cancers that can be cured by excisional surgery at the same time as achieving excellent cosmetic results. 18 ultrasound is particularly effective at increasing good prognosis breast cancer detection in the mammographically dense breast. 19 the american college of radiology Imaging network (acrIn) trial demonstrated that combining ultrasound with mammography led to an additional 4.2 cancers detected per 1,000 women with elevated cancer risk due to dense breast parenchyma. 20 the majority of these cancers were small and axillary node negative. these findings have prompted some to suggest that supplemental ultrasound should be routine in 
The images show the improved sensitivity and specificity of digital breast tomosynthesis (DBT) images. The mass in the upper breast is indeterminate on the 2D image (A), but is clearly shown to be a normal axillary tail lymph node on the DBT image (B). There is a small breast cancer in the lower breast that is not well seen on the 2D images that is unequivocal on the DBT section. Images courtesy of Dr Gisella Gennaro -Istituto Oncologico Veneto, Padua, Italy.
screening women with dense breasts. However, there are significant drawbacks to the routine use of ultrasound in screening. Firstly, ultrasound is operator dependent, which impacts on its reproducibility.
most studies have used experienced radiologists with specific scanning protocols to perform the examination and it is unlikely that this level of expertise can be provided for the millions of women that with dense breast that would qualify for this additional screening test. another obstacle in implementing ultrasound as routine in screening is its poor comparative specificity with high Fpr, significant increases in benign biopsy rates, and, hence, decrease in the positive predictive value (ppV) of screening for cancer. In screening programmes using mammography alone, the recall rate that results in biopsy is in the range 1-3 % but in the acrIn trial the recalls that led to biopsy rose to 8.9 % with a resultant decrease in the ppV of 50 %. the advantage of DcE-mrI is the combination of morphological features and functional dynamic enhancement characteristics, which give the greatest sensitivity for cancer detection (see Figure 3) . 36 Figure 3) . 45 the improved sensitivity as well as specificity afforded by using DWI in conjunction with DcE-mrI could in practice prevent a third of biopsies. these discrepancies are likely related to the numbers employed in each study and in part to the way regions of interest were drawn and further research in this area is warranted. overall, however, the aDc is considered a promising adjunctive imaging biomarker that can identify highly aggressive breast cancer.
proton magnetic resonance spectroscopy (1H-mrS) is another functional technique that provides information in vivo on the molecular content of tissues and their metabolism and can also improve the specificity of DcE-mrI up to 88 %. 54, 55 In breast cancer, high levels of cholinecontaining metabolites are involved in phosopholipid metabolism and indicate cellular membranes in proliferation resulting in a triplet peak at 3.22 ppm of free choline, phosphocholine and glycerophosphocholine.
choline is almost undetectable in normal breast tissue and a peak at 
Dual-modality Imaging
although a combination of modalities can be used in the investigation of breast cancer, dual-modality systems have been prototyped with the aim of performing two imaging modalities using the same equipment.
this has the potential to improve speed and more accurate coregistration of abnormalities. automated ultrasound can be combined with ct or breast mrI and this should make biopsy easier to achieve. 
Conclusion
Imaging of the breast is now regarded as essential for detection and diagnosis of breast disease. mammography and ultrasound remain the standard front-line techniques and dramatic improvements in digital technology mean that these techniques remain highly effective for both screening and symptomatic disease evaluation. In the screening setting it is likely that DBt will soon become routine, with resultant improved detection and dramatic decrease in Fprs. contrastenhanced mrI is now established as the most sensitive technique for the breast and new technologies in mrI hardware, imaging sequences and breast-specific contrast agents will mean increasing use of breast mrI in routine practice for detection, assessment of disease burden, and response to treatment. there are a number of novel technologies and reiterations of older technology being evaluated for the breast, but
these have yet to be proved in clinical practice. n
